Clinical trial
Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive…
NCT00077207 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00077207 |
|---|---|
| Title | Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma |
| Official title | A Pilot Study Using Carboplatin, Vincristine And Temozolomide For Children ≤ 10 Years With Progressive/Symptomatic Low-Grade Gliomas |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Brain Tumor, Central Nervous System Tumor |
| Intervention type | Drug |
| Interventions | carboplatin, temozolomide, vincristine sulfate |
| Enrollment | 66 |
| Start date | Jul 1, 2004 |
| Primary completion | Mar 1, 2010 |
| Completion | Dec 1, 2013 |
| First posted | Feb 11, 2004 |
| Last update posted | May 16, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: